Septic Shock:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Septic Shock Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Septic Shock 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Septic Shock 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Septic Shock Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Ferring Pharmaceuticals, Inc. 35
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 35
Shenzhen Neptunus Pharmaceutical Company Limited 36
Clinical Trial Overview of Shenzhen Neptunus Pharmaceutical Company Limited 36
Adrenomed AG 37
Clinical Trial Overview of Adrenomed AG 37
Gambro KK 38
Clinical Trial Overview of Gambro KK 38
Immunexpress Pty Ltd 39
Clinical Trial Overview of Immunexpress Pty Ltd 39
Laboratoire Francais de Fractionnement et de Biotechnologies SA 40
Clinical Trial Overview of Laboratoire Francais de Fractionnement et de Biotechnologies SA 40
Axis-Shield Diagnostics Limited 41
Clinical Trial Overview of Axis-Shield Diagnostics Limited 41
Aventis Behring GmbH 42
Clinical Trial Overview of Aventis Behring GmbH 42
Apex Bioscience, Inc. 43
Clinical Trial Overview of Apex Bioscience, Inc. 43
Eisai Inc. 44
Clinical Trial Overview of Eisai Inc. 44
Green Cross Corporation 45
Clinical Trial Overview of Green Cross Corporation 45
UMC Utrecht Holding BV 46
Clinical Trial Overview of UMC Utrecht Holding BV 46
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Sirius Genomics Inc. 48
Clinical Trial Overview of Sirius Genomics Inc. 48
GlaxoSmithKline plc 49
Clinical Trial Overview of GlaxoSmithKline plc 49
Clinical Trial Overview of Top Institutes / Government 50
Sapienza University of Rome 50
Clinical Trial Overview of Sapienza University of Rome 50
Beth Israel Deaconess Medical Center 51
Clinical Trial Overview of Beth Israel Deaconess Medical Center 51
University of Manitoba 52
Clinical Trial Overview of University of Manitoba 52
Charite – Universitatsmedizin Berlin 53
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 53
Assistance Publique – Hopitaux de Paris 54
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 54
Radboud University 55
Clinical Trial Overview of Radboud University 55
Herlev Hospital 56
Clinical Trial Overview of Herlev Hospital 56
Rennes University Hospital 57
Clinical Trial Overview of Rennes University Hospital 57
University of Versailles 58
Clinical Trial Overview of University of Versailles 58
The University of Texas Health Science Center at Houston 59
Clinical Trial Overview of The University of Texas Health Science Center at Houston 59
The Medical Center Leeuwarden 60
Clinical Trial Overview of The Medical Center Leeuwarden 60
Carolinas Healthcare System 61
Clinical Trial Overview of Carolinas Healthcare System 61
University Hospital, Grenoble 62
Clinical Trial Overview of University Hospital, Grenoble 62
Southeast University 63
Clinical Trial Overview of Southeast University 63
Hadassah Medical Organization 64
Clinical Trial Overview of Hadassah Medical Organization 64
University Hospital Inselspital, Berne 65
Clinical Trial Overview of University Hospital Inselspital, Berne 65
Hospices Civils de Lyon 66
Clinical Trial Overview of Hospices Civils de Lyon 66
University Hospital, Angers 67
Clinical Trial Overview of University Hospital, Angers 67
National Taiwan University Hospital 68
Clinical Trial Overview of National Taiwan University Hospital 68
VU University Medical Center 69
Clinical Trial Overview of VU University Medical Center 69
Five Key Clinical Profiles 70
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 96


【レポート販売概要】

■ タイトル:Septic Shock:グローバル臨床試験レビューH2, 2013
■ 英文:Septic Shock Global Clinical Trials Review, H2, 2013
■ 発行日:2013年8月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161972
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。